期刊文献+

高效液相色谱-电喷雾质谱(HPLC-ESI-MS/MS)测定新型抗癌铂配合物 被引量:4

Application of HPLC-ESI-MS/MS to the Determination of a Novel Antitumour Platinum Complex
下载PDF
导出
摘要 A novel platinum complex,named as saliplatin,was designed,synthesized and characterized with element analysis,coupled inductively plasma-mass spectrum,gravitational thermal-differential thermal analysis,ultraviolet-visible absorption spectrum,infrared spectrum,fast atom bombment mass spectrum and 1H NMR,etc.Its purity was investigated and determined.HPLC-ESI-MS was employed to separate the platinum complex and the impurity,and to identify and quantify the latter.It proved that the impurity in this novel compound was 3,5-diisopropylsalycilic acid,a reactant used in the synthesis of the novel platinum complex,identified with ESI-MS.The mass fraction was determined with HPLC as 4.3%,which meant that the purity of this new substance was 95.7%. A novel platinum complex, named as saliplatin, was designed, synthesized and characterized with element analysis, coupled inductively plasma-mass spectrum, gravitational thermal-differential thermal analysis, ultraviolet-visible absorption spectrum, infrared spectrum, fast atom bombment mass spectrum and I H NMR, etc. Its purity was investigated and determined. HPLC-ESI-MS was employed to separate the platinum complex and the impurity, and to identify and quantify the latter. It proved that the impurity in this novel compound was 3,5-diisopropylsalycilic acid, a reactant used in the synthesis of the novel platinum complex, identified with ESI-MS. The mass fraction was determined with HPLC as 4. 3%, which meant that the purity of this new substance was 95.7%.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2007年第8期1486-1488,共3页 Chemical Journal of Chinese Universities
基金 清华大学裕元医学研究基金(批准号:20240000529)资助
关键词 电喷雾质谱 铂配合物 抗癌药物 ESI-MS Platinum complex Antitumour drug
  • 相关文献

参考文献11

  • 1Draqovich T. , Mendelson D. , Hoos A. , et al.. Colorectal Cancer[J], 2003, 9:583
  • 2Saito T. , Manabe Y, , Saito H.. J. Otorhinolaryngol Relat. Spec. [J], 1995, 57(5) : 235-255
  • 3HoYee-Ping, Steve Au-Yeung, Medicinal Research Reviews [ J ], 2003, 23 (5) : 633-655
  • 4Takeki Uehara, Hiroshi Watanaba, Fumio Itoh, et al.. Arch. Toxicol. [J], 2005, 79:451-460
  • 5陈宝卫,StellaS.G.E.VanBoom,JanReedljk.铂配合物cis-[Pt(NH_3)_2(4-mepy)Cl]NO_3与甲基-谷胱甘肽作用的NMR研究[J].高等学校化学学报,1997,18(6):840-845. 被引量:2
  • 6贾木欣,曲雯雯,陈光巨,刘若庄.铂类抗肿瘤药物ZD0473与双链及单链DNA作用差异的理论研究[J].高等学校化学学报,2004,25(8):1481-1484. 被引量:11
  • 7YU Yao(余尧).Study of a Novel Antitumour Platinum Compound [ D ], Kunming: Institute of Precious Metal, 2006
  • 8Francesco Tisato, Cristina Bolzati, Marina Porchia, et al.. Mass Spectrometry Reviews[ J ] , 2004, 23:309-332
  • 9Valerio B. Di Marco, Bombi G. Giorgio. Mass Spectrometry Reviews[J] , 2006, 25:347-379
  • 10Meng Cui, Zolta'n Mester. Rapid Commun. Mass Spectrom. [J], 2003, 17:1517-1527

二级参考文献11

  • 1Jamieson E. R. , Lippard S. J.. Chem. Rev.[J], 1999, 99(8): 2467-2498
  • 2Wang E. , Giandomenico C. M.. Chem. Rev. [J], 1999, 99(8): 2 451-2 466
  • 3Chen Y.,Parkison J.A.,Guo Z.et al..Angew.Chem.Int.Ed.[J],1999,38(13/14):2 060-2 063
  • 4Chen Y. , Guo Z. , Parkinson J. A. et al.. J. Chem. Soc. Dalton Trans. [J], 1998:3 577-3 585
  • 5Svensson M. , Humbel S. , Froese R. D. J.. J. Phys. Chem. [J], 1996, 100: 19 357-19 363
  • 6Hay P. J. ,Wadt W. R.. J. Chem. Phys. [J], 1985, 82(1): 270-283
  • 7Becke A. D.. J. Phys. Chem. [J], 1993, 98:5 648-5 652
  • 8Lee C. , Duman W. , Parr R. G.. Phys. Rev. B. [J], 1988, 37:785-789
  • 9Wong M. W., Frisch M. J., Wiberg K. B.. J. Am. Chem. Soc. [J], 1991, 113: 4 776-4 782
  • 10张志刚,杨频.二茂钛二甘氨酸盐酸盐与DNA作用机理的研究[J].高等学校化学学报,1997,18(8):1259-1261. 被引量:10

共引文献11

同被引文献79

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部